Captopril restores endothelium-dependent relaxation of rat aortic rings after exposure to homocysteine

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 4, 2003, Pages 566-572

  Fu, Yun Feng ^a   Xiong, Yan ^a   Fu, Si Hai ^a  

^a Central South University   (China)

Author keywords

Captopril; Endothelium dependent relaxation; Homocysteine; L arginine; Rat; Superoxide dismutase; Thoracic aorta

Indexed keywords

ACETYLCHOLINE; ARGININE; CAPTOPRIL; HOMOCYSTEINE; NITROPRUSSIDE SODIUM; OXYGEN RADICAL; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; SCAVENGING SYSTEM; VASCULAR ENDOTHELIUM; VASCULAR RING; VASODILATATION;

ACETYLCHOLINE; ANIMALS; AORTA, THORACIC; ARGININE; CAPTOPRIL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; HOMOCYSTEINE; MALE; MUSCLE RELAXATION; MUSCLE, SMOOTH, VASCULAR; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; VASODILATION;

EID: 0141641147     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200310000-00016     Document Type: Article

References (35)

1. Ungvari Z, Pacher P, Rischák K, et al. Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperhomocysteinemia. Arterioscler Thromb Vasc Biol. 1999;19:1899-1904.
2. Böger RH, Bode-Böger SM, Sydow K, et al. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arterioscler Thromb Vasc Biol. 2000;20:1557-1564.
3. Tawakol A, Omland T, Gerhard M, et al. Hyperhomocys-t(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation. 1997;95:1119-1121.
4. Woo KS, Chook P, Lolin YI, et al. Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans. Circulation. 1997;96:2542-2544.
5. Emsley AM, Jeremy JY, Gomes GN, et al. Investigation of the inhibitory effects of homocysteine and copper on nitric oxide-mediated relaxation of rat isolated aorta. Br J Pharmacol. 1999;126:1034-1040.
6. Lang D, Kredan MB, Moat SJ, et al. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. Arterioscler Thromb Vasc Biol. 2000;20:422-427.
7. Lentz SR, Piegors DJ, Malinow MR, et al. Supplementation of atherogenic diet with B vitamins does not prevent atherosclerosis or vascular dysfunction in monkeys. Circulation. 2001;103:1006-1011.
8. Homig B, Bode-Boger SM, Arakawa N, et al. Lack of improvement of homocyst(e)ine-induced endothelial dysfunction during supplementation with B vitamins in patients with arterial occlusive disease. Circulation. 1999;100(suppl I):I-757.
9. Thambyrajah J, Landray MJ, Wheeler DC, et al. A randomised trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease. Circulation. 2000;102(suppl II):II-703.
10. Thambyrajah J, Landray MJ, McGlynn FJ, et al. Does folic acid decrease plasma homocysteine and improve endothelial function in patients with predialysis renal failure? Circulation. 2000;102:871-875.
11. Pullin CH, Ashfield-Watt PA, Burr ML, et al. Optimization of dietary folate or low-dose folic acid supplements lower homocysteine but do not enhance endothelial function in healthy adults, irrespective of the methylene-tetrahydrofolate reductase (C677T) genotype. J Am Coll Cardiol. 2001;38:1799-1805.
12. Chan NN, Chan WB, Chan JC. Reduction of total homocysteine levels by oral folic acid fails to improve endothelial function in children with chronic renal failure. Circulation. 2003;107:e6-e7.
13. Sydow K, Schwedhelm E, Arakawa N, et al. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins. Cardiovasc Res. 2003;57:244-252.
14. 6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA. 2002;288:973-979.
15. Keaton AK, White CR, Berecek KH. Captopril treatment and its withdrawal prevents impairment of endothelium-dependent responses in the spontaneously hypertensive rat. Clin Exp Hypertens. 1998;20:847-866.
16. Mancini GBJ, Henry GC, Macaya C, et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing Endothelial Dysfunction) Study. Circulation. 1996;94:258-265.
17. Jacobsen DW, Gatautis VJ, Green R, et al. Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin. Chem. 1994;40:873-881.
18. Kang SS, Wong PW, Malinow MR. Hyperhomocysteinemia as a risk factor for occlusive vascular disease. Ann Rev Nutr. 1992;12:279-298.
19. Upchurch GR Jr, Welch GN, Fabian AJ, et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem. 1997;272:17012-17017.
20. Raghuveer G, Sinkey CA, Chenard C, et al. Effect of vitamin E on resistance vessel endothelial dysfunction induced by methionine. Am J Cardiol. 2001;88:285-290.
21. Stuhlinger MC, Tsao PS, Her JH, et al. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 2001;104:2569-2575.
22. Chow K, Cheung F, Lao TT, et al. Effect of homocysteine on the production of nitric oxide in endothelial cells. Clin Exp Pharmacol Physiol. 1999;26:817-818.
23. Zhang X, Li H, Jin H, et al. Effects of homocys-teine on endothelial nitric oxide production. Am J Physiol Renal Physiol. 2000;279:F671-F678.
24. Bode-Böger SM, Böger RH, Kienke S, et al. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun. 1996;219:598-603.
25. Xiong Y, Lu R, Li YJ, et al. Elevation of an endogenous inhibitor of nitric oxide synthase in diabetic rat serum. Acta Pharmacol Sin. 1997;18:511-514.
26. Xiong Y, Yuan LW, Deng HW, et al. Elevated serum endogenous inhibitor of nitric oxide synthase and endothelial dysfunction in aged rats. Clin Exp Pharmacol Physiol. 2001;28:842-847.
27. Hernandez A, Barberi L, Ballerio R, et al. Delapril slows the progression of atherosclerosis and maintains endothelial function in cholesterol-fed rabbits. Atherosclerosis. 1998;137:71-76.
28. Chao CL, Lee YT. Impairment of cerebrovascular reactivity by methionine-induced hyperhomocysteinemia and amelioration by quinapril treatment. Stroke. 2000;31:2907-2911.
29. Liao DF, Chen X. Prostacyclin-mediated protection of angiotensin converting enzyme inhibitors against injury of aortic endothelium by free radicals. Cardioscience. 1992;3:79-84.
30. Ota Y, Kugiyama K, Sugiyama S, et al. Impairment of endothelium-dependent relaxation of rabbit aortas by cigarette smoke extract - role of free radicals and attenuation by captopril. Atherosclerosis. 1997;131:195-202.
31. Zhou ZH, Jiang JL, Peng J, et al. Reversal of tolerance to nitroglycerin with N-acetylcysteine or captopril: a role of calcitonin gene-related peptide. Eur J Pharmacol. 2002;439:129-134.
32. Goldschmidt JE, Tallarida RJ. Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor. J Pharmacol Exp Ther. 1991;257:1136-1145.
33. Chopra M, Beswick H, Clapperton M, et al. Antioxidant effects of angiotensin-converting enzyme (ACE) inhibitors: free radical and oxidant scavenging are sulfhydryl dependent, but lipid peroxidation is inhibited by both sulfhydryl- and nonsulfhydryl-containing ACE inhibitors. J Cardiovasc Pharmacol. 1992;19:330-340.
34. Grafe M, Bossaller C, Graf K, et al. Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells. Am J Physiol. 1993;264:H1493-H1497.
35. Xiong Y, Deng HW, Li YJ, et al. Nitric oxide mediates the protective effect of ramiprilat against damages of rabbit aortic endothelium by oxygen free radicals. Chin J Pharmacol Toxicol. 1994;8:241-245.